Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,508 | 131,777 | 139,520 | 146,920 | 24,930 |
| Marketable Securities | 39,000 | N/A | 0 | N/A | 20,000 |
| TOTAL | $127,075 | $134,522 | $140,052 | $147,684 | $46,325 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 439 | 607 | 893 | 1,056 | 1,131 |
| TOTAL | $439 | $607 | $893 | $1,056 | $1,131 |
| Total Assets | $127,514 | $135,129 | $140,945 | $148,740 | $47,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,557 | 574 | 619 | 1,809 | 1,544 |
| Accrued Expenses | 3,281 | 3,585 | 2,714 | 1,945 | 4,197 |
| TOTAL | $5,203 | $4,700 | $3,988 | $4,406 | $6,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 96,398 | 96,398 | 99,828 | 245,479 | 397 |
| TOTAL | $96,398 | $96,398 | $99,828 | $245,479 | $397 |
| Total Liabilities | $101,601 | $101,098 | $103,816 | $249,885 | $6,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,017 | 13,009 | 12,827 | 3,904 | 3,904 |
| Common Shares | 13 | 13 | 77 | 23 | 4 |
| Retained earnings | -455,809 | -446,318 | -438,447 | -430,981 | -260,897 |
| TOTAL | $25,913 | $34,031 | $37,129 | $-101,145 | $40,669 |
| Total Liabilities And Equity | $127,514 | $135,129 | $140,945 | $148,740 | $47,456 |